Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New test to diagnose thrombosis tendency]

Freja Ebeling1, Tom Pettersson, Leila Muukkonen

  • 1Suomen Punaisen Ristin Veripalvelu, Plasmavalmisteet Kivihaantie 7 00310 Helsinki. freja.ebeling@veripalvelu.fi

Duodecim; Laaketieteellinen Aikakauskirja
|December 5, 2002
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-cell analysis of aplastic anemia reveals a convergence of NK and NK-like CD8<sup>+</sup> T cells with a disease-associated TCR signature.

Science translational medicine·2025
Same author

Influence of Cytogenetics on the Outcome of Patients With High-Risk Myelodysplastic Syndrome Including Deletion 5q Treated With Azacitidine With or Without Lenalidomide.

Genes, chromosomes & cancer·2025
Same author

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same author

Clonal dynamics using droplet digital polymerase chain reaction in peripheral blood predicts treatment responses in myelodysplastic syndrome.

Haematologica·2022
Same author

Sequential high-sensitivity mutational and chimerism analyses predict responses to post-transplant salvage therapies in MDS.

Bone marrow transplantation·2022
Same author

"Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)".

Leukemia·2022